601 related articles for article (PubMed ID: 29656891)
1. Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.
Mitchell TJ; Turajlic S; Rowan A; Nicol D; Farmery JHR; O'Brien T; Martincorena I; Tarpey P; Angelopoulos N; Yates LR; Butler AP; Raine K; Stewart GD; Challacombe B; Fernando A; Lopez JI; Hazell S; Chandra A; Chowdhury S; Rudman S; Soultati A; Stamp G; Fotiadis N; Pickering L; Au L; Spain L; Lynch J; Stares M; Teague J; Maura F; Wedge DC; Horswell S; Chambers T; Litchfield K; Xu H; Stewart A; Elaidi R; Oudard S; McGranahan N; Csabai I; Gore M; Futreal PA; Larkin J; Lynch AG; Szallasi Z; Swanton C; Campbell PJ;
Cell; 2018 Apr; 173(3):611-623.e17. PubMed ID: 29656891
[TBL] [Abstract][Full Text] [Related]
2. Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinoma.
Köhn L; Svenson U; Ljungberg B; Roos G
Appl Immunohistochem Mol Morphol; 2015; 23(5):334-42. PubMed ID: 24992170
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
[TBL] [Abstract][Full Text] [Related]
4. Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma.
Kroeger N; Klatte T; Chamie K; Rao PN; Birkhäuser FD; Sonn GA; Riss J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
Cancer; 2013 Apr; 119(8):1547-54. PubMed ID: 23335244
[TBL] [Abstract][Full Text] [Related]
5. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
Beroukhim R; Brunet JP; Di Napoli A; Mertz KD; Seeley A; Pires MM; Linhart D; Worrell RA; Moch H; Rubin MA; Sellers WR; Meyerson M; Linehan WM; Kaelin WG; Signoretti S
Cancer Res; 2009 Jun; 69(11):4674-81. PubMed ID: 19470766
[TBL] [Abstract][Full Text] [Related]
6. Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.
Favazza L; Chitale DA; Barod R; Rogers CG; Kalyana-Sundaram S; Palanisamy N; Gupta NS; Williamson SR
Mod Pathol; 2017 Nov; 30(11):1603-1612. PubMed ID: 28731045
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations in sporadic renal-cell carcinoma: molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p.
Brauch H; Pomer S; Hieronymus T; Schadt T; Löhrke H; Komitowski D
World J Urol; 1994; 12(3):162-8. PubMed ID: 7951344
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic studies of 24 renal epithelial tumors with von Hippel-Lindau and fragile histidine triad protein expression correlation.
Gayrard N; Cacheux V; Iborra F; Mourad G; Argilés A
Arch Pathol Lab Med; 2008 Jun; 132(6):965-73. PubMed ID: 18517280
[TBL] [Abstract][Full Text] [Related]
10. Independent Tumor Origin in Two Cases of Synchronous Bilateral Clear Cell Renal Cell Carcinoma.
Ji Z; Zhao J; Zhao T; Han Y; Zhang Y; Ye H
Sci Rep; 2016 Jul; 6():29267. PubMed ID: 27383411
[TBL] [Abstract][Full Text] [Related]
11. PBRM1 and BAP1 as novel targets for renal cell carcinoma.
Brugarolas J
Cancer J; 2013; 19(4):324-32. PubMed ID: 23867514
[TBL] [Abstract][Full Text] [Related]
12. Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study.
Hughson MD; Schmidt L; Zbar B; Daugherty S; Meloni AM; Silva FG; Sandberg AA
J Am Soc Nephrol; 1996 Nov; 7(11):2461-8. PubMed ID: 8959640
[TBL] [Abstract][Full Text] [Related]
13. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
[TBL] [Abstract][Full Text] [Related]
14. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
15. Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes.
Woodward ER; Clifford SC; Astuti D; Affara NA; Maher ER
J Med Genet; 2000 May; 37(5):348-53. PubMed ID: 10807693
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
17. Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.
Turajlic S; Xu H; Litchfield K; Rowan A; Horswell S; Chambers T; O'Brien T; Lopez JI; Watkins TBK; Nicol D; Stares M; Challacombe B; Hazell S; Chandra A; Mitchell TJ; Au L; Eichler-Jonsson C; Jabbar F; Soultati A; Chowdhury S; Rudman S; Lynch J; Fernando A; Stamp G; Nye E; Stewart A; Xing W; Smith JC; Escudero M; Huffman A; Matthews N; Elgar G; Phillimore B; Costa M; Begum S; Ward S; Salm M; Boeing S; Fisher R; Spain L; Navas C; Grönroos E; Hobor S; Sharma S; Aurangzeb I; Lall S; Polson A; Varia M; Horsfield C; Fotiadis N; Pickering L; Schwarz RF; Silva B; Herrero J; Luscombe NM; Jamal-Hanjani M; Rosenthal R; Birkbak NJ; Wilson GA; Pipek O; Ribli D; Krzystanek M; Csabai I; Szallasi Z; Gore M; McGranahan N; Van Loo P; Campbell P; Larkin J; Swanton C;
Cell; 2018 Apr; 173(3):595-610.e11. PubMed ID: 29656894
[TBL] [Abstract][Full Text] [Related]
18. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
19. A clearer view of the molecular complexity of clear cell renal cell carcinoma.
Frew IJ; Moch H
Annu Rev Pathol; 2015; 10():263-89. PubMed ID: 25387056
[TBL] [Abstract][Full Text] [Related]
20. Differential Expression of PD-L1 Between Sporadic and VHL-Associated Hereditary Clear-Cell Renal Cell Carcinoma and Its Correlation With Clinicopathological Features.
Hong B; Cai L; Wang J; Liu S; Zhou J; Ma K; Zhang J; Zhou B; Peng X; Zhang N; Gong K
Clin Genitourin Cancer; 2019 Apr; 17(2):97-104.e1. PubMed ID: 30522901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
